Impact of the per-operatory application of GLIADEL wafers (BCNU, carmustine) in combination with temozolomide and radiotherapy in patients with glioblastoma multiforme: Efficacy and toxicity-Reference-Cited by-同舟云学术

Impact of the per-operatory application of GLIADEL wafers (BCNU, carmustine) in combination with temozolomide and radiotherapy in patients with glioblastoma multiforme: Efficacy and toxicity

Published:2012-11 Issue:9 Volume:114 Page:1222-1225
ISSN:0303-8467
Container-title:Clinical Neurology and Neurosurgery
language:en
Short-container-title:Clinical Neurology and Neurosurgery

Author:

Miglierini Petra,Bouchekoua Mohamed,Rousseau Benoit,Dam Hieu Phong,Malhaire Jean-Pierre,Pradier Olivier

Publisher

Elsevier BV

Subject

Clinical Neurology,General Medicine,Surgery

Reference20 articles.

1. Descriptive epidemiology of primary brain and CNS tumours: results from the Central Brain Tumour Registry of the United States, 1990–1994;Surawicz;Neuro-oncol,1999

2. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

3. Placebo-controlled trail of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas;Brem;Lancet,1995

4. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU wafers) in patients with primary malignant glioma;Westphal;Neuro Oncol,2003

5. Gliadel® wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial;Westphal;Acta Neurochir (Wien),2006

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Doxorubicin-loaded liposome-like particles embedded in chitosan/hyaluronic acid-based hydrogels as a controlled drug release model for local treatment of glioblastoma;International Journal of Biological Macromolecules;2024-10

2. Carmustine wafer implantation for supratentorial glioblastomas, IDH-wildtype in “extreme” neurosurgical conditions;Neurosurgical Review;2023-06-17

3. Polymer nanocarriers for targeted local delivery of agents in treating brain tumors;Nanotechnology;2022-12-02

4. Design of Bio-Responsive Hyaluronic Acid–Doxorubicin Conjugates for the Local Treatment of Glioblastoma;Pharmaceutics;2022-01-05

5. Temperature and pH-responsive in situ hydrogels of gelatin derivatives to prevent the reoccurrence of brain tumor;Biomedicine & Pharmacotherapy;2021-11